ArticleBritish journal of cancer2014

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.

M J M Gooden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.